Sugi Predict

Sugi Predict / Compounds / SCHEMBL896203

SCHEMBL896203

SCHEMBL896203

C=Cc1ccc(-c2ccccc2)c(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 1/20 0.54
▸ CYP1A1 P04798 3/20 0.46
▸ CYP1A2 P05177 3/20 0.46
▸ CYP1B1 Q16678 3/20 0.46
▸ CYP2E1 P05181 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C8 P10632 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2A6 P11509 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP4B1 P13584 1/20 0.46
▸ CYP2B6 P20813 1/20 0.46
▸ CYP3A5 P20815 1/20 0.46
▸ CYP2A7 P20853 1/20 0.46
▸ CYP3A7 P24462 1/20 0.46
▸ CYP2F1 P24903 1/20 0.46
▸ CYP2C18 P33260 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ CYP2J2 P51589 1/20 0.46
▸ CYP4F2 P78329 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30882817 0.85 TRPA1 (0.66) TRPA1CYP1A1CYP1A2CYP1B1TUBB1
SCHEMBL2570296 0.83 TTR (0.59) CYP1A1CYP1A2CYP1B1CYP2E1CYP3A4
SCHEMBL10486971 0.83 FDPS (0.51) CYP1A1CYP1A2CYP1B1CYP2E1CYP3A4
SCHEMBL9132416 0.82 PTPRC (0.42) TRPA1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL11528857 0.80 TUBB4A (0.51) TRPA1CYP1A1CYP1A2CYP1B1TUBB1
SCHEMBL13039489 0.80 TRPA1 (0.47) TRPA1CYP1A1CYP1B1
Styrene SCHEMBL4407984 0.79 CYP1A1 (0.68) TRPA1CYP1A1CYP1A2CYP1B1TUBB1
SCHEMBL896204 0.79 XDH (0.47) TRPA1PGRALDH1A1TSHRAPP
SCHEMBL11673432 0.78 HTR7 (0.51) TRPA1CYP1A1CYP1A2CYP1B1CYP2E1
SCHEMBL3757526 0.77 ALDH1A1 (0.48) TRPA1ALDH1A1HPGDTSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9184428-B2 Non-aqueous electrolytes for lithium ion batteries UCHICAGO ARGONNE LLC (US) 2015-11-10 — — US claimed
US-9012096-B2 Long life lithium batteries with stabilized electrodes UCHICAGO ARGONNE, LLC (US) 2015-04-21 — — US claimed
US-7851092-B2 Redox shuttles for overcharge protection of lithium batteries U CHICAGO ARGONNE LLC (US) 2010-12-14 — — US claimed
WO-2006101779-A2 NON-AQUEOUS ELECTROLYTES FOR LITHIUM ION BATTERIES THE UNIVERSITY OF CHICAGO (US) 2006-09-28 — — WO claimed
US-20060210883-A1 Non-aqueous electrolytes for lithium ion batteries THE UNIVERSITY OF CHICAGO 2006-09-21 — — US claimed
WO-2006094069-A2 NOVEL REDOX SHUTTLES FOR OVERCHARGE PROTECTION OF LITHIUM BATTERIES UCHICAGO ARGONNE, LLC (US) 2006-09-08 — — WO claimed
US-20060199080-A1 Novel redox shuttles for overcharge protection of lithium batteries THE UNIVERSITY OF CHICAGO 2006-09-07 — — US claimed
US-20060147809-A1 Non-aqueous electrolyte of an alkali metal salt, a polar aprotic solvent, and an electrode stabilization additive comprising a linear, branched or cyclic hydrocarbon, other than a spirocyclic hydrocarbon, comprising at least one oxygen atom and at least one aryl, alkenyl or alkynyl group THE UNIVERSITY OF CHICAGO 2006-07-06 — — US claimed
US-4027041-A Ethyl- and vinylbenzenes as antithrombotic agents ELI LILLY AND COMPANY (US) 1977-05-31 — — US claimed
US-4024284-A Ethyl- and vinylbenzenes as anti-inflammatory agents ELI LILLY AND COMPANY (US) 1977-05-17 — — US claimed
US-12327844-B2 Materials to improve the performance of lithium and sodium batteries UCHICAGO ARGONNE, LLC (US) 2025-06-10 — — US disclosed
EP-3656010-B1 PHOSPHORUS-CONTAINING ELECTROLYTES SIONIC ENERGY INC (US) 2025-03-26 — — EP disclosed
US-20250079514-A1 SILYL ENOLATES FOR USE IN LITHIUM BATTERY ELECTROLYTES UCHICAGO ARGONNE, LLC (US) 2025-03-06 — — US disclosed
US-12155038-B2 Modified ionic liquids containing bicyclophosphate moiety Sionic Energy, Inc. (US) 2024-11-26 — — US disclosed
US-12021226-B2 Cathode materials for secondary batteries UCHICAGO ARGONNE, LLC (US) 2024-06-25 — — US disclosed
EP-0444210-A1 ARYLSTYRENE POLYMER AND COPOLYMER AND PROCESS FOR PREPARING THE SAME IDEMITSU KOSAN COMPANY LIMITED (JP) 1991-09-04 — — EP disclosed
US-4027041-A Ethyl- and vinylbenzenes as antithrombotic agents ELI LILLY AND COMPANY (US) 1977-05-31 — — US disclosed
US-4024284-A Ethyl- and vinylbenzenes as anti-inflammatory agents ELI LILLY AND COMPANY (US) 1977-05-17 — — US disclosed
US-3975542-A Ethyl- and vinylbenzenes as antithromobiotic agents ELI LILLY AND COMPANY (US) 1976-08-17 — — US disclosed
US-3975543-A Ethyl- and vinylbenzenes as anti-inflammatory agents ELI LILLY AND COMPANY (US) 1976-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250079514-A1 SILYL ENOLATES FOR USE IN LITHIUM BATTERY ELECTROLYTES SELENOI, SLC10A1, SLC9A3 TRPA1 2594/4885CYP1A1 2498/4885CYP1A2 1806/4885
US-12155038-B2 Modified ionic liquids containing bicyclophosphate moiety IPMK, PPIP5K2, OSGEP TRPA1 464/4885CYP1A1 4363/4885CYP1A2 4116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.